Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin vs placebo for heroin craving, withdrawal and stress response
IRCT2015103024792N1Phase 2Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in opioid withdrawal and opioid use disorder (OUD) comparing Oxytocin with Placebo (2 arms). Primary endpoints: Heroin craving, Withdrawal symptoms and 1 more. Started Oct 2015; status: completed.
02
Drugs
oxytocin
03
Conditions
opioid withdrawalopioid use disorder (OUD)
Beyond the preview
Go deeper on IRCT2015103024792N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015103024792N1.